Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1198 entries
Sorted by: Best Match Show Resources per page
Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension.

Respirology case reports

Sato T, Tsujino I, Tanino M, Ohira H, Nishimura M.
PMID: 25473528
Respirol Case Rep. 2013 Sep;1(1):10-3. doi: 10.1002/rcr2.7.

A 69-year-old man with progressive dyspnea was referred to our hospital in Oct 2010. The patient was clinically diagnosed with combined pulmonary fibrosis and emphysema (CPFE) and pulmonary hypertension (PH). Sildenafil and bosentan were used for the treatment of...

Cite
Sato T, Tsujino I, Tanino M, et al. Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension. Respirol Case Rep. 2013;1(1):10-3doi: 10.1002/rcr2.7.
Sato, T., Tsujino, I., Tanino, M., Ohira, H., & Nishimura, M. (2013). Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension. Respirology case reports, 1(1), 10-3. https://doi.org/10.1002/rcr2.7
Sato, Takahiro, et al. "Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension." Respirology case reports vol. 1,1 (2013): 10-3. doi: https://doi.org/10.1002/rcr2.7
Sato T, Tsujino I, Tanino M, Ohira H, Nishimura M. Broad and heterogeneous vasculopathy in pulmonary fibrosis and emphysema with pulmonary hypertension. Respirol Case Rep. 2013 Sep;1(1):10-3. doi: 10.1002/rcr2.7. PMID: 25473528; PMCID: PMC4184639.
Copy Download .nbib Format: NLM
Madden-Julian Oscillation prediction skill of a new-generation global model demonstrated using a supercomputer.

Nature communications

Miyakawa T, Satoh M, Miura H, Tomita H, Yashiro H, Noda AT, Yamada Y, Kodama C, Kimoto M, Yoneyama K.
PMID: 24801254
Nat Commun. 2014 May 06;5:3769. doi: 10.1038/ncomms4769.

Global cloud/cloud system-resolving models are perceived to perform well in the prediction of the Madden-Julian Oscillation (MJO), a huge eastward -propagating atmospheric pulse that dominates intraseasonal variation of the tropics and affects the entire globe. However, owing to model...

Cite
Miyakawa T, Satoh M, Miura H, et al. Madden-Julian Oscillation prediction skill of a new-generation global model demonstrated using a supercomputer. Nat Commun. 2014;5:3769doi: 10.1038/ncomms4769.
Miyakawa, T., Satoh, M., Miura, H., Tomita, H., Yashiro, H., Noda, A. T., Yamada, Y., Kodama, C., Kimoto, M., & Yoneyama, K. (2014). Madden-Julian Oscillation prediction skill of a new-generation global model demonstrated using a supercomputer. Nature communications, 53769. https://doi.org/10.1038/ncomms4769
Miyakawa, Tomoki, et al. "Madden-Julian Oscillation prediction skill of a new-generation global model demonstrated using a supercomputer." Nature communications vol. 5 (2014): 3769. doi: https://doi.org/10.1038/ncomms4769
Miyakawa T, Satoh M, Miura H, Tomita H, Yashiro H, Noda AT, Yamada Y, Kodama C, Kimoto M, Yoneyama K. Madden-Julian Oscillation prediction skill of a new-generation global model demonstrated using a supercomputer. Nat Commun. 2014 May 06;5:3769. doi: 10.1038/ncomms4769. PMID: 24801254; PMCID: PMC4024761.
Copy Download .nbib Format: NLM
Synthesis and aggregation behaviour of luminescent mesomorphic zinc(II) complexes with 'salen' type asymmetric Schiff base ligands.

Dalton transactions (Cambridge, England : 2003)

Chakraborty S, Bhattacharjee CR, Mondal P, Prasad SK, Rao DS.
PMID: 25803004
Dalton Trans. 2015 Apr 28;44(16):7477-88. doi: 10.1039/c4dt03989k.

A new series of photoluminescent Zn(II)-salen type asymmetric Schiff base complexes, [ZnL], H2L = [N,N'-bis-(4-n-alkoxysalicylidene)-1,2-diaminopropane] (n = 12, 14 and 16) have been accessed and their mesomorphic and photophysical properties investigated. Though the ligands are non-mesomorphic, coordination to Zn(2+)...

Cite
Chakraborty S, Bhattacharjee CR, Mondal P, et al. Synthesis and aggregation behaviour of luminescent mesomorphic zinc(II) complexes with 'salen' type asymmetric Schiff base ligands. Dalton Trans. 2015;44(16):7477-88doi: 10.1039/c4dt03989k.
Chakraborty, S., Bhattacharjee, C. R., Mondal, P., Prasad, S. K., & Rao, D. S. (2015). Synthesis and aggregation behaviour of luminescent mesomorphic zinc(II) complexes with 'salen' type asymmetric Schiff base ligands. Dalton transactions (Cambridge, England : 2003), 44(16), 7477-88. https://doi.org/10.1039/c4dt03989k
Chakraborty, Sutapa, et al. "Synthesis and aggregation behaviour of luminescent mesomorphic zinc(II) complexes with 'salen' type asymmetric Schiff base ligands." Dalton transactions (Cambridge, England : 2003) vol. 44,16 (2015): 7477-88. doi: https://doi.org/10.1039/c4dt03989k
Chakraborty S, Bhattacharjee CR, Mondal P, Prasad SK, Rao DS. Synthesis and aggregation behaviour of luminescent mesomorphic zinc(II) complexes with 'salen' type asymmetric Schiff base ligands. Dalton Trans. 2015 Apr 28;44(16):7477-88. doi: 10.1039/c4dt03989k. PMID: 25803004.
Copy Download .nbib Format: NLM
Late-onset acetaminophen-induced allergic hepatitis with progression to chronicity.

Hepatology research : the official journal of the Japan Society of Hepatology

Mishima-Iwai M, Takahashi K, Yokode M, Kimura Y, Sawai Y, Ueda Y, Chiba T.
PMID: 25088083
Hepatol Res. 2015 Jul;45(7):814-7. doi: 10.1111/hepr.12399. Epub 2014 Sep 02.

Acetaminophen (paracetamol), a widely used antipyretic/analgesic, is a well-known agent causing acute hepatic injury. Whereas most cases are caused by its intrinsic hepatotoxicity, idiosyncratic hepatitis by the allergic mechanism is extremely rare. We herein report a case of late-onset...

Cite
Mishima-Iwai M, Takahashi K, Yokode M, et al. Late-onset acetaminophen-induced allergic hepatitis with progression to chronicity. Hepatol Res. 2014;45(7):814-7doi: 10.1111/hepr.12399.
Mishima-Iwai, M., Takahashi, K., Yokode, M., Kimura, Y., Sawai, Y., Ueda, Y., & Chiba, T. (2015). Late-onset acetaminophen-induced allergic hepatitis with progression to chronicity. Hepatology research : the official journal of the Japan Society of Hepatology, 45(7), 814-7. https://doi.org/10.1111/hepr.12399
Mishima-Iwai, Masako, et al. "Late-onset acetaminophen-induced allergic hepatitis with progression to chronicity." Hepatology research : the official journal of the Japan Society of Hepatology vol. 45,7 (2015): 814-7. doi: https://doi.org/10.1111/hepr.12399
Mishima-Iwai M, Takahashi K, Yokode M, Kimura Y, Sawai Y, Ueda Y, Chiba T. Late-onset acetaminophen-induced allergic hepatitis with progression to chronicity. Hepatol Res. 2015 Jul;45(7):814-7. doi: 10.1111/hepr.12399. Epub 2014 Sep 02. PMID: 25088083.
Copy Download .nbib Format: NLM
Kidney Regeneration: Lessons from Development.

Current pathobiology reports

Chiba T, Hukriede N, de Caestecker MP.
PMID: 26120499
Curr Pathobiol Rep. 2015 Mar;3(1):67-79. doi: 10.1007/s40139-015-0069-z.

A number of genes involved in kidney development are reactivated in the adult after acute kidney injury (AKI). This has led to the belief that tissue repair mechanisms recapitulate pathways involved in embryonic development after AKI. We will discuss...

Cite
Chiba T, Hukriede N, de Caestecker MP. Kidney Regeneration: Lessons from Development. Curr Pathobiol Rep. 2015;3(1):67-79doi: 10.1007/s40139-015-0069-z.
Chiba, T., Hukriede, N., & de Caestecker, M. P. (2015). Kidney Regeneration: Lessons from Development. Current pathobiology reports, 3(1), 67-79. https://doi.org/10.1007/s40139-015-0069-z
Chiba, Takuto, et al. "Kidney Regeneration: Lessons from Development." Current pathobiology reports vol. 3,1 (2015): 67-79. doi: https://doi.org/10.1007/s40139-015-0069-z
Chiba T, Hukriede N, de Caestecker MP. Kidney Regeneration: Lessons from Development. Curr Pathobiol Rep. 2015 Mar;3(1):67-79. doi: 10.1007/s40139-015-0069-z. PMID: 26120499; PMCID: PMC4477536.
Copy Download .nbib Format: NLM
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma.

Hepatology international

Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O.
PMID: 26201804
Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12.

PURPOSE: Sorafenib induces early vascularity reduction in patients with hepatocellular carcinoma (HCC). We sought to identify differences in radiological assessment approaches and to evaluate their usefulness for the prediction of the initial response to sorafenib.METHODS: Forty-eight patients with advanced...

Cite
Ogasawara S, Kanai F, Ooka Y, et al. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013;7(2):703-13doi: 10.1007/s12072-013-9425-4.
Ogasawara, S., Kanai, F., Ooka, Y., Motoyama, T., Suzuki, E., Tawada, A., Chiba, T., & Yokosuka, O. (2013). Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatology international, 7(2), 703-13. https://doi.org/10.1007/s12072-013-9425-4
Ogasawara, Sadahisa, et al. "Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma." Hepatology international vol. 7,2 (2013): 703-13. doi: https://doi.org/10.1007/s12072-013-9425-4
Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12. PMID: 26201804.
Copy Download .nbib Format: NLM
Oxidative and Hydrolytic Stability of Synthetic Diacyl Glyceryl Ether.

Bioscience, biotechnology, and biochemistry

Endo Y, Chiba T, Fujimoto K.
PMID: 27299396
Biosci Biotechnol Biochem. 1996 Jan;60(2):216-9. doi: 10.1271/bbb.60.216.

Diacyl glyceryl ethers (DGEs) as present in marine animals were chemically synthesized and then were assessed for their oxidative and hydrolytic stabilities. CDD and CEE were easily autoxidized but not COO. The autoxidation rate of DGEs followed the unsaturation...

Cite
Endo Y, Chiba T, Fujimoto K. Oxidative and Hydrolytic Stability of Synthetic Diacyl Glyceryl Ether. Biosci Biotechnol Biochem. 1996;60(2):216-9doi: 10.1271/bbb.60.216.
Endo, Y., Chiba, T., & Fujimoto, K. (1996). Oxidative and Hydrolytic Stability of Synthetic Diacyl Glyceryl Ether. Bioscience, biotechnology, and biochemistry, 60(2), 216-9. https://doi.org/10.1271/bbb.60.216
Endo, Y, et al. "Oxidative and Hydrolytic Stability of Synthetic Diacyl Glyceryl Ether." Bioscience, biotechnology, and biochemistry vol. 60,2 (1996): 216-9. doi: https://doi.org/10.1271/bbb.60.216
Endo Y, Chiba T, Fujimoto K. Oxidative and Hydrolytic Stability of Synthetic Diacyl Glyceryl Ether. Biosci Biotechnol Biochem. 1996 Jan;60(2):216-9. doi: 10.1271/bbb.60.216. PMID: 27299396.
Copy Download .nbib Format: NLM
Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma.

Case reports in oncology

Kanogawa N, Chiba T, Ogasawara S, Ooka Y, Suzuki E, Motoyama T, Saito T, Sekimoto T, Tawada A, Maruyama H, Yoshikawa M, Yokosuka O.
PMID: 25685134
Case Rep Oncol. 2014 Dec 19;7(3):833-9. doi: 10.1159/000370305. eCollection 2014.

Radiofrequency ablation (RFA) is commonly used as a treatment for small hepatocellular carcinoma (HCC). Although several complications such as intraperitoneal bleeding are often observed after RFA, hepatic arterioportal fistula (APF) is a less frequently occurring complication. In this study,...

Cite
Kanogawa N, Chiba T, Ogasawara S, et al. Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma. Case Rep Oncol. 2014;7(3):833-9doi: 10.1159/000370305.
Kanogawa, N., Chiba, T., Ogasawara, S., Ooka, Y., Suzuki, E., Motoyama, T., Saito, T., Sekimoto, T., Tawada, A., Maruyama, H., Yoshikawa, M., & Yokosuka, O. (2014). Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma. Case reports in oncology, 7(3), 833-9. https://doi.org/10.1159/000370305
Kanogawa, Naoya, et al. "Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma." Case reports in oncology vol. 7,3 (2014): 833-9. doi: https://doi.org/10.1159/000370305
Kanogawa N, Chiba T, Ogasawara S, Ooka Y, Suzuki E, Motoyama T, Saito T, Sekimoto T, Tawada A, Maruyama H, Yoshikawa M, Yokosuka O. Successful interventional treatment for arterioportal fistula caused by radiofrequency ablation for hepatocellular carcinoma. Case Rep Oncol. 2014 Dec 19;7(3):833-9. doi: 10.1159/000370305. eCollection 2014. PMID: 25685134; PMCID: PMC4307006.
Copy Download .nbib Format: NLM
Involvement of the Ventrolateral Prefrontal Cortex in Learning Others' Bad Reputations and Indelible Distrust.

Frontiers in human neuroscience

Suzuki A, Ito Y, Kiyama S, Kunimi M, Ohira H, Kawaguchi J, Tanabe HC, Nakai T.
PMID: 26869908
Front Hum Neurosci. 2016 Feb 04;10:28. doi: 10.3389/fnhum.2016.00028. eCollection 2016.

A bad reputation can persistently affect judgments of an individual even when it turns out to be invalid and ought to be disregarded. Such indelible distrust may reflect that the negative evaluation elicited by a bad reputation transfers to...

Cite
Suzuki A, Ito Y, Kiyama S, et al. Involvement of the Ventrolateral Prefrontal Cortex in Learning Others' Bad Reputations and Indelible Distrust. Front Hum Neurosci. 2016;10:28doi: 10.3389/fnhum.2016.00028.
Suzuki, A., Ito, Y., Kiyama, S., Kunimi, M., Ohira, H., Kawaguchi, J., Tanabe, H. C., & Nakai, T. (2016). Involvement of the Ventrolateral Prefrontal Cortex in Learning Others' Bad Reputations and Indelible Distrust. Frontiers in human neuroscience, 1028. https://doi.org/10.3389/fnhum.2016.00028
Suzuki, Atsunobu, et al. "Involvement of the Ventrolateral Prefrontal Cortex in Learning Others' Bad Reputations and Indelible Distrust." Frontiers in human neuroscience vol. 10 (2016): 28. doi: https://doi.org/10.3389/fnhum.2016.00028
Suzuki A, Ito Y, Kiyama S, Kunimi M, Ohira H, Kawaguchi J, Tanabe HC, Nakai T. Involvement of the Ventrolateral Prefrontal Cortex in Learning Others' Bad Reputations and Indelible Distrust. Front Hum Neurosci. 2016 Feb 04;10:28. doi: 10.3389/fnhum.2016.00028. eCollection 2016. PMID: 26869908; PMCID: PMC4740734.
Copy Download .nbib Format: NLM
Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis.

Clinical journal of gastroenterology

Sato S, Saito R, Iwadate H, Asano T, Abe K, Takahashi A, Kobayashi H, Watanabe H, Ohira H.
PMID: 26182396
Clin J Gastroenterol. 2012 Aug;5(4):292-7. doi: 10.1007/s12328-012-0321-6. Epub 2012 Jul 20.

A 40-year-old man with acute meningitis, nephrotic syndrome, elevated antinuclear antibody (2560×), and liver dysfunction was referred to our hospital. He was antimitochondrial antibody positive, and renal and liver biopsy findings revealed membranous nephropathy (MN) and primary biliary cirrhosis...

Cite
Sato S, Saito R, Iwadate H, et al. Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis. Clin J Gastroenterol. 2012;5(4):292-7doi: 10.1007/s12328-012-0321-6.
Sato, S., Saito, R., Iwadate, H., Asano, T., Abe, K., Takahashi, A., Kobayashi, H., Watanabe, H., & Ohira, H. (2012). Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis. Clinical journal of gastroenterology, 5(4), 292-7. https://doi.org/10.1007/s12328-012-0321-6
Sato, Shuzo, et al. "Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis." Clinical journal of gastroenterology vol. 5,4 (2012): 292-7. doi: https://doi.org/10.1007/s12328-012-0321-6
Sato S, Saito R, Iwadate H, Asano T, Abe K, Takahashi A, Kobayashi H, Watanabe H, Ohira H. Membranous nephropathy associated with primary biliary cirrhosis and acute meningitis. Clin J Gastroenterol. 2012 Aug;5(4):292-7. doi: 10.1007/s12328-012-0321-6. Epub 2012 Jul 20. PMID: 26182396.
Copy Download .nbib Format: NLM
Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer.

Endoscopy international open

Watanabe K, Hikichi T, Sato M, Nakamura J, Obara K, Ohira H.
PMID: 27227121
Endosc Int Open. 2016 May;4(5):E597-602. doi: 10.1055/s-0042-105202. Epub 2016 Apr 21.

BACKGROUND: Gastric emptying after endoscopic submucosal dissection (ESD) for early gastric cancer is not clear. The aim of this study was to evaluate changes in gastric emptying from before ESD to 8 weeks after ESD.METHODS: In total, 54 patients...

Cite
Watanabe K, Hikichi T, Sato M, et al. Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer. Endosc Int Open. 2016;4(5):E597-602doi: 10.1055/s-0042-105202.
Watanabe, K., Hikichi, T., Sato, M., Nakamura, J., Obara, K., & Ohira, H. (2016). Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer. Endoscopy international open, 4(5), E597-602. https://doi.org/10.1055/s-0042-105202
Watanabe, Ko, et al. "Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer." Endoscopy international open vol. 4,5 (2016): E597-602. doi: https://doi.org/10.1055/s-0042-105202
Watanabe K, Hikichi T, Sato M, Nakamura J, Obara K, Ohira H. Change in gastric emptying eight weeks after endoscopic submucosal dissection in patients with early gastric cancer. Endosc Int Open. 2016 May;4(5):E597-602. doi: 10.1055/s-0042-105202. Epub 2016 Apr 21. PMID: 27227121; PMCID: PMC4874802.
Copy Download .nbib Format: NLM
Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis.

Oncotarget

Kanda T, Yasui S, Nakamura M, Nakamoto S, Takahashi K, Wu S, Sasaki R, Haga Y, Ogasawara S, Saito T, Kobayashi K, Kiyono S, Ooka Y, Suzuki E, Chiba T, Maruyama H, Imazeki F, Moriyama M, Kato N.
PMID: 29545925
Oncotarget. 2018 Feb 03;9(14):11631-11637. doi: 10.18632/oncotarget.24391. eCollection 2018 Feb 20.

BACKGROUND: Interferon-free treatment can achieve higher sustained virological response (SVR) rates, even in patients in whom hepatitis C virus (HCV) could not be eradicated in the interferon treatment era. Immune restoration in the liver is occasionally associated with HCV...

Cite
Kanda T, Yasui S, Nakamura M, et al. Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget. 2018;9(14):11631-11637doi: 10.18632/oncotarget.24391.
Kanda, T., Yasui, S., Nakamura, M., Nakamoto, S., Takahashi, K., Wu, S., Sasaki, R., Haga, Y., Ogasawara, S., Saito, T., Kobayashi, K., Kiyono, S., Ooka, Y., Suzuki, E., Chiba, T., Maruyama, H., Imazeki, F., Moriyama, M., & Kato, N. (2018). Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget, 9(14), 11631-11637. https://doi.org/10.18632/oncotarget.24391
Kanda, Tatsuo, et al. "Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis." Oncotarget vol. 9,14 (2018): 11631-11637. doi: https://doi.org/10.18632/oncotarget.24391
Kanda T, Yasui S, Nakamura M, Nakamoto S, Takahashi K, Wu S, Sasaki R, Haga Y, Ogasawara S, Saito T, Kobayashi K, Kiyono S, Ooka Y, Suzuki E, Chiba T, Maruyama H, Imazeki F, Moriyama M, Kato N. Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget. 2018 Feb 03;9(14):11631-11637. doi: 10.18632/oncotarget.24391. eCollection 2018 Feb 20. PMID: 29545925; PMCID: PMC5837765.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1198 entries